These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36952240)

  • 1. Variability in
    Ghosh AJ; Moll M; Hobbs BD; Cardwell J; Saferali A; Castaldi PJ; Cho MH; Silverman EK; Yang IV; Hersh CP
    Am J Respir Crit Care Med; 2023 May; 207(10):1401-1404. PubMed ID: 36952240
    [No Abstract]   [Full Text] [Related]  

  • 2. Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways.
    Schwartz DA
    Ann Am Thorac Soc; 2018 Nov; 15(Suppl 3):S192-S197. PubMed ID: 30431344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment.
    Biondini D; Cocconcelli E; Bernardinello N; Lorenzoni G; Rigobello C; Lococo S; Castelli G; Baraldo S; Cosio MG; Gregori D; Saetta M; Balestro E; Spagnolo P
    Respir Res; 2021 Apr; 22(1):98. PubMed ID: 33794872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC5B promoter polymorphism and pulmonary fibrosis.
    Zhang GY; Liao T; Gao WY
    N Engl J Med; 2011 Jul; 365(2):178; author reply 178-9. PubMed ID: 21751917
    [No Abstract]   [Full Text] [Related]  

  • 5. A common MUC5B promoter polymorphism and pulmonary fibrosis.
    Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
    N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between the promoter
    Stock CJ; Conti C; Montero-Fernandez Á; Caramori G; Molyneaux PL; George PM; Kokosi M; Kouranos V; Maher TM; Chua F; Rice A; Denton CP; Nicholson AG; Wells A; Sestini P; Renzoni EA
    Thorax; 2020 Oct; 75(10):901-903. PubMed ID: 32580994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering
    Zhang Q; Wang Y; Qu D; Yu J; Yang J
    Biomed Res Int; 2019; 2019():9712464. PubMed ID: 31309122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC5B and Idiopathic Pulmonary Fibrosis.
    Yang IV; Fingerlin TE; Evans CM; Schwarz MI; Schwartz DA
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S193-9. PubMed ID: 26595739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC5B: a good target for future therapy in pulmonary fibrosis?
    Mahida R; Turner AM
    Thorax; 2013 May; 68(5):401. PubMed ID: 23329274
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis.
    Jiang H; Hu Y; Shang L; Li Y; Yang L; Chen Y
    Int J Clin Exp Pathol; 2015; 8(11):14953-8. PubMed ID: 26823827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of MUC5B Expression in Idiopathic Pulmonary Fibrosis.
    Helling BA; Gerber AN; Kadiyala V; Sasse SK; Pedersen BS; Sparks L; Nakano Y; Okamoto T; Evans CM; Yang IV; Schwartz DA
    Am J Respir Cell Mol Biol; 2017 Jul; 57(1):91-99. PubMed ID: 28272906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC5B Promoter Polymorphism and Survival in Indian Patients With Idiopathic Pulmonary Fibrosis.
    Dhooria S; Bal A; Sehgal IS; Prasad KT; Kashyap D; Sharma R; Muthu V; Agarwal R; Aggarwal AN
    Chest; 2022 Oct; 162(4):824-827. PubMed ID: 35405109
    [No Abstract]   [Full Text] [Related]  

  • 13. MUC5B Promoter Variant rs35705950 Affects MUC5B Expression in the Distal Airways in Idiopathic Pulmonary Fibrosis.
    Nakano Y; Yang IV; Walts AD; Watson AM; Helling BA; Fletcher AA; Lara AR; Schwarz MI; Evans CM; Schwartz DA
    Am J Respir Crit Care Med; 2016 Feb; 193(4):464-6. PubMed ID: 26871673
    [No Abstract]   [Full Text] [Related]  

  • 14. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
    Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
    Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Air Pollution and MUC5B Genotype on Survival in Idiopathic Pulmonary Fibrosis.
    Sesé L; Borie R; Kannengiesser C; Cottin V; Israel-Biet D; Crestani B; Cadranel J; Chenivesse C; Boubaya M; Valeyre D; Annesi-Maesano I; Nunes H;
    Ann Am Thorac Soc; 2024 Mar; 21(3):519-523. PubMed ID: 38096447
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis.
    Okamoto T; Mathai SK; Hennessy CE; Hancock LA; Walts AD; Stefanski AL; Brown KK; Lynch DA; Cosgrove GP; Groshong SD; Cool CD; Schwarz MI; Banda NK; Thurman JM; Yang IV; Holers VM; Schwartz DA
    Am J Physiol Lung Cell Mol Physiol; 2018 Jul; 315(1):L1-L10. PubMed ID: 29565179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucking around in the Genome: MUC5B in Idiopathic Pulmonary Fibrosis.
    Kolb M; White ES; Gauldie J
    Am J Respir Crit Care Med; 2016 Feb; 193(4):355-7. PubMed ID: 26871671
    [No Abstract]   [Full Text] [Related]  

  • 18. TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
    Oldham JM; Ma SF; Martinez FJ; Anstrom KJ; Raghu G; Schwartz DA; Valenzi E; Witt L; Lee C; Vij R; Huang Y; Strek ME; Noth I;
    Am J Respir Crit Care Med; 2015 Dec; 192(12):1475-82. PubMed ID: 26331942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC5B promoter polymorphism and pulmonary fibrosis.
    Burch LH
    N Engl J Med; 2011 Jul; 365(2):178; author reply 178-9. PubMed ID: 21751916
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias.
    van der Vis JJ; Snetselaar R; Kazemier KM; ten Klooster L; Grutters JC; van Moorsel CH
    Respirology; 2016 May; 21(4):712-7. PubMed ID: 26699835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.